17-75238289-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_138619.4(GGA3):c.2162G>A(p.Gly721Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,461,202 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138619.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250648Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135472
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461202Hom.: 0 Cov.: 34 AF XY: 0.0000124 AC XY: 9AN XY: 726926
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2162G>A (p.G721E) alteration is located in exon 17 (coding exon 17) of the GGA3 gene. This alteration results from a G to A substitution at nucleotide position 2162, causing the glycine (G) at amino acid position 721 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at